BioMarin Pharmaceutical Inc (BMRN) bonds
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$58.51+0.52 (+0.90%)
Close on Nov 17, 2026Market cap $11.33BP/E 154.0Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$4.19B
$658.20M due within a year
Net debt
$3.31B
After $874.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
37.6×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in BioMarin Pharmaceutical's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| 1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes) Convertible at $137 a share | 1.25% | 2027 | $600.00M | $600.00M |
| 5.5% senior unsecured notes due in February 2034 (the 2034 Notes) | 5.50% | – | $850.00M | $850.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Available | Drawn |
|---|---|---|---|
| Revolving Credit Facility | $600.00M | – | – |
| Senior Secured Revolving Credit Facility | $600.00M | $600.00M | – |
| Senior Secured Term Loan A Facility | $800.00M | – | $800.00M |
| Senior Secured Term Loan B Facility | $2.00B | – | $2.00B |
See a number that looks wrong?